Forsythe, A., Chandiwana, D., Barth, J., Thabane, M., Baeck, J., Shor, A., & Tremblay, G. (2018). Is progression-free survival a more relevant endpoint than overall survival in first-line HR+/HER2− metastatic breast cancer? Cancer Manag Res.

Forsythe, Anna, David Chandiwana, Janina Barth, Marroon Thabane, Johan Baeck, Anastasiya Shor, và Gabriel Tremblay. "Is Progression-free Survival a More Relevant Endpoint Than Overall Survival in First-line HR+/HER2− Metastatic Breast Cancer?" Cancer Manag Res 2018.

Forsythe, Anna, et al. "Is Progression-free Survival a More Relevant Endpoint Than Overall Survival in First-line HR+/HER2− Metastatic Breast Cancer?" Cancer Manag Res 2018.